While promising, epigenetic therapies face several challenges:
1. Specificity: Achieving specificity in targeting cancer cells without affecting normal cells remains a significant challenge. 2. Resistance: Cancer cells may develop resistance to epigenetic drugs, necessitating combination therapies. 3. Side Effects: Epigenetic drugs can have off-target effects, leading to toxicity and other adverse reactions.
